Literature DB >> 9353053

Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.

R A Saladino1, A M Stack, G R Fleisher, C M Thompson, D E Briles, L Kobzik, G R Siber.   

Abstract

We have developed a model of low-inoculum Streptococcus pneumoniae infection in infant rats. We challenged 4-day-old Sprague-Dawley pups via intraperitoneal or intrapulmonary injection of S. pneumoniae serotypes 1, 3, 4, 5, 6b, 7f, 9v, 14, 19f, and 23f. To achieve bacteremia with low inocula, it was necessary to passage the isolates in rats. Inocula of the 10 S. pneumoniae serotypes producing bacteremia in 50% or more animals ranged from 1 to 400 CFU. Virulence was similar by intraperitoneal and intrapulmonary routes. Lung specimens from animals challenged by the intrapulmonary route grew S. pneumoniae and demonstrated histologic evidence of focal infection. Meningitis was detected in 20 to 50% of bacteremic animals, and mortality invariably followed bacteremia within 24 to 48 h. This model of intrapulmonary infection uses low inocula of S. pneumoniae and results in bacteremia, meningitis, and death in infant rats.

Entities:  

Mesh:

Year:  1997        PMID: 9353053      PMCID: PMC175674          DOI: 10.1128/iai.65.11.4701-4704.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Pneumococcal disease: prospects for a new generation of vaccines.

Authors:  G R Siber
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

2.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

3.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

4.  Antibodies against pneumococcal C-polysaccharide are not protective.

Authors:  S V Nielsen; U B Sørensen; J Henrichsen
Journal:  Microb Pathog       Date:  1993-04       Impact factor: 3.738

5.  Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Authors:  W S Pomat; D Lehmann; R C Sanders; D J Lewis; J Wilson; S Rogers; T Dyke; M P Alpers
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 6.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Authors:  I R Friedland; G H McCracken
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

7.  Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.

Authors:  P P Vella; S Marburg; J M Staub; P J Kniskern; W Miller; A Hagopian; C Ip; R L Tolman; C M Rusk; L S Chupak
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand.

Authors:  L Voss; D Lennon; K Okesene-Gafa; S Ameratunga; D Martin
Journal:  Pediatr Infect Dis J       Date:  1994-10       Impact factor: 2.129

9.  Pneumococcal bacteremia in Charleston County, South Carolina. A decade later.

Authors:  R F Breiman; J S Spika; V J Navarro; P M Darden; C P Darby
Journal:  Arch Intern Med       Date:  1990-07

10.  Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro.

Authors:  C M MacLEOD; M R KRAUS
Journal:  J Exp Med       Date:  1950-07-01       Impact factor: 14.307

View more
  8 in total

1.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.

Authors:  L Piroth; L Martin; A Coulon; C Lequeu; M Duong; M Buisson; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum.

Authors:  Alice L Erwin; Simon Allen; Derek K Ho; Paul J Bonthuis; Paul J Bonthius; Justin Jarisch; Kevin L Nelson; David L Tsao; William C T Unrath; Michael E Watson; Bradford W Gibson; Michael A Apicella; Arnold L Smith
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Infant rat infection modifies phenotypic properties of an invasive nontypeable Haemophilus influenzae.

Authors:  David Tsao; Kevin L Nelson; Daniel Kim; Arnold L Smith
Journal:  Microbes Infect       Date:  2011-12-27       Impact factor: 2.700

5.  Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Anthony M Smith; Charles Feldman; Orietta Massidda; Kerrigan McCarthy; Dalu Ndiweni; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 6.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 7.  Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain.

Authors:  Geeta Ramesh; Andrew G MacLean; Mario T Philipp
Journal:  Mediators Inflamm       Date:  2013-08-12       Impact factor: 4.711

8.  Development of a model of focal pneumococcal pneumonia in young rats.

Authors:  Richard Malley; Anne M Stack; Robert N Husson; Claudette M Thompson; Gary R Fleisher; Richard A Saladino
Journal:  J Immune Based Ther Vaccines       Date:  2004-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.